Antithrombotic ethers

Details Antithrombotic ethers Antithrombotic ethers

2004-04-13

2009-11-10

Solola, Taofiq A (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S270700

Reexamination Certificate

active

07615568

ABSTRACT:
This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor (I).

REFERENCES:
patent: 6140351 (2000-10-01), Arnaiz et al.
patent: 6313122 (2001-11-01), Beight et al.
patent: 6313151 (2001-11-01), Beight et al.
patent: 6372759 (2002-04-01), Beight et al.
patent: 6417200 (2002-07-01), Beight et al.
patent: 6610704 (2003-08-01), Beight et al.
patent: 6635657 (2003-10-01), Beight et al.
patent: 6689780 (2004-02-01), Beight et al.
patent: 2004/0058959 (2004-03-01), Herron et al.
patent: 2004/0097491 (2004-05-01), Herron et al.
patent: 2004/0242581 (2004-12-01), Herron et al.
patent: WO 02/10154 (2002-02-01), None
patent: WO 02/064567 (2002-08-01), None
patent: WO 2005/049604 (2005-06-01), None
Zhu, et al.: “Factor Xa Inhibitors: Recent Advances in Anticoagulant Agents” Annual Reports in Medicinal Chemistry, (2000), 35, 83-102.

Affiliated with

Also associated with

Rating

Antithrombotic ethers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antithrombotic ethers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antithrombotic ethers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4083452